Brown Brothers Harriman & Co’s Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares CLVT.PRA Stock Holding History

Brown Brothers Harriman & Co’s Portfolio CLVT.PRA Stock Details CLVT.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-588,596	Closed	-$17.5M	–	1249
2024 Q1	$17.5M	Hold	588,596	–	–	0.13%	87
2023 Q4	$22.5M	Hold	588,596	–	–	0.19%	58
2023 Q3	$17.2M	Hold	588,596	–	–	0.15%	66
2023 Q2	$24.2M	Hold	588,596	–	–	0.19%	53
2023 Q1	$24.2M	Hold	588,596	–	–	0.2%	53
2022 Q4	$22.3M	Hold	588,596	–	–	0.2%	56
2022 Q3	$25.1M	Hold	588,596	–	–	0.23%	55
2022 Q2	$33.7M	Buy	588,596 +388,596	+194%	+$23.8M	0.29%	51
2022 Q1	$13.6M	Buy	+200,000	New	+$13.5M	0.1%	76

Brown Brothers Harriman & Co's CLVT.PRA Position: Q2 2024 in Review

Brown Brothers Harriman & Co sold out of Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares (CLVT.PRA) in Q2 2024, closing a stake of 588,596 shares — an estimated $17.5M sold.

Brown Brothers Harriman & Co first reported a position in CLVT.PRA in Q1 2022 and held it in 9 quarters. The position peaked at $33.7M in Q2 2022. 0 funds tracked by Wall St. Rank hold CLVT.PRA as of Q2 2024.

Brown Brothers Harriman & Co reported no remaining Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares position as of Q2 2024 after selling out during the quarter.
Brown Brothers Harriman & Co sold 588,596 Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares shares in Q2 2024, an estimated $17.5M.
Brown Brothers Harriman & Co first reported a position in Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares in Q1 2022 and held it in 9 quarters.
Brown Brothers Harriman & Co's Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares position peaked at $33.7M in Q2 2022.
0 funds tracked by Wall St. Rank held Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares as of Q2 2024.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2024, filed 9 Aug 2024.